Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2026-06-30 17:25:10 ET · period of report 2026-06-29 · accession 0001159036-26-000082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-30 17:25 | 2026-06-29 | HALO | Krishnan Mahesh | Dir | M - OptEx | $38.46 | +7,304 | 21.8K | +51% | +$280.9K |
| DT | 2026-06-30 17:25 | 2026-06-29 | HALO | Krishnan Mahesh | Dir | S - Sale+OE | $75.00 | -7,304 | 14.5K | -34% | -$547.8K |
| DT | 2026-06-30 17:25 | 2026-06-29 | HALO | Krishnan Mahesh | Dir | M - OptEx | $0.00 | -7,304 | 1,500 | -83% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-29 | M | A | 7,304 | $38.46 | 21,766 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-29 | S | D | 7,304 | $75.00 | 14,462 | D | — | — | (F1) The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 19, 2026 in accordance with Rule 10b5-1. |
| 3 | Derivative | Option to Purchase Common Stock | 2026-06-29 | M | D | 7,304 | $0.00 | 1,500 | D | $38.46 · — to 2034-04-25 | 7,304 Common Stock | (F2) Grant to Reporting Person of options exercisable as of April 25, 2025. |